MR CLEAN: TOR Affects Treatment Efficacy in Patients With Acute Ischemic Stroke

Summary

An analysis of the MR CLEAN trial demonstrated a significant interaction between time from stroke onset to reperfusion and treatment effect, with the decrease in absolute risk difference between treated and untreated patients of almost 7% per hour (P = .038). The relationship between time to treatment and treatment effect was not statistically significant but is still considered biologically plausible.

  • acute ischemic stroke
  • endovascular
  • intra-arterial
  • MR CLEAN
  • TOR
  • TOT
View Full Text